Webinar

Delivery Devices for Net Zero: Sustainability in the Injectable Device Value Chain

This on-demand webinar explores how the Alliance to Zero — a non-profit membership association founded in 2021 — is developing science-based, third-party certified greenhouse gas reduction KPIs across the injectable device supply chain, and what pharma and biotech companies must do to meet net zero commitments by 2030 and 2050.

Status Published

Format Webinar

Language English

Access Registration Required

Watch the Webinar

Resource Overview

About this Webinar

Approximately 71% of healthcare emissions are linked to supply chain activities — including the production, transport, and disposal of drugs, chemical agents, and medical devices — yet the pharmaceutical industry has been widely recognized as lagging behind other sectors in tackling greenhouse gas emissions. This on-demand webinar introduces the Alliance to Zero, a non-profit membership association founded in 2021 by pharmaceutical and biotech supply chain companies committed to achieving net zero emissions in alignment with the Paris Climate Agreement. The session outlines the Alliance's inclusive, science-based methodology for establishing transparent, third-party certified greenhouse gas reduction KPIs across the injectable device value chain — spanning primary packaging and filling, secondary packaging, labeling and assembly, and end-of-life management. Topics include the current state of pharma sustainability pledges and the critical role of supply chain partners in enabling manufacturers to reach their 2030 and 2050 goals, the Alliance's roadmap for delivering net zero pharma products by 2030.

Approximately 71% of healthcare emissions are linked to supply chain activities — including production, transport, and disposal of drugs and devices — yet pharma has lagged other industries in tackling emissions, making supplier collaboration the critical lever for meeting net zero commitments.
The Alliance to Zero is developing transparent, third-party certified GHG reduction KPIs across the injectable device value chain — from primary packaging through end-of-life — with an ambition to deliver net zero pharma products by 2030.
Monomaterial secondary packaging innovations, such as Körber's flat carton blanks and paper fiber trays produced on top-loading equipment, demonstrate how supply chain redesign can reduce packaging volume, lower transport emissions, and support circular economy goals simultaneously.

Watch the Webinar

Watch the Webinar On-Demand

Start the on-demand session instantly after quick registration.

Watch the Webinar

Quick access in under 30 seconds.

Delivery Devices for Net Zero: Sustainability in the Injectable Device Value Chain

About this Webinar

Watch the Webinar On-Demand

More Drug Delivery Devices Resources

Datwyler Healthcare Product Portfolio

Sealing Solutions for Cartridges

Comprehensive Solutions for GLP-1 Drugs

Stay informed on Datwyler Healthcare technical resources